U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07431866) titled 'A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)' on Feb. 19.
Brief Summary: Researchers are looking for other ways to treat people who have heart failure with preserved ejection fraction (HFpEF). HFpEF is a type of heart failure where the heart becomes stiff and does not relax properly. MK-2828 is a study medicine designed to treat HFpEF.
The main goal of the study is to learn if MK-2828 affects what happens to rosuvastatin or furosemide in the body.
Study Start Date: April 03
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Rosuvastatin
Oral administra...